☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
chronic kidney disease
AstraZeneca at ERA 2024: Regina Fritsche-Danielson in an Illuminating Dialogue Exchange with PharmaShots
August 26, 2024
Unlocking Approval: Mohamed Eid Dives into the Exciting Approval of Jardiance for Adult CKD Treatment in a Captivating Chat with P...
December 6, 2023
GSK Presents Results of Daprodustat in P-III ASCEND Program for the Treatment of Anemia due to Chronic Kidney Disease at ASN Kidne...
November 8, 2021
PharmaShots Interview: Astellas' Txema Sanz Shares Insights on the Evrenzo (roxadustat) for Symptomatic Anemia Associated with Chr...
October 27, 2021
AstraZeneca's Forxiga (dapagliflozin) Receives MHLW's Approval for the Treatment of Chronic Kidney Disease in Patients with and wi...
August 26, 2021
Astellas and FibroGen's Evrenzo (roxadustat) Receive EC's Approval for Symptomatic Anemia Associated with Chronic Kidney Disease
August 20, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.